Taking a Fresh Look at Diebold Nixdorf, Incorporated (DBD)

Diebold Nixdorf, Incorporated (DBD) is an interesting player in the Technology space, with a focus on Diversified Computer Systems. The stock has been active on the tape, currently trading at $14.55, down from yesterday’s close by -1.02%. Given the stock’s recent action, it seemed like a good time to take a closer look at the company’s recent data.

Fundamental Analysis

Diebold Nixdorf, Incorporated (DBD) currently trades with a market capitalization of $1.18 Billion. That value represents a market adjusting for revenues that have been growing by 14.18 % on a quarterly year/year basis as of the company’s last quarterly report.

You can get a sense of how sustainable that is by a levered free cash flow of -$69.3 Million over the past twelve months. Generally speaking, earnings are expected to fall in coming quarters. Analysts are forecasting earnings of $0.35 on a per share basis this quarter. Perhaps, that suggests something about why 2.96% of the outstanding share supply is held by institutional investors.

Technical Analysis

It’s important to check the technicals to get a sense of how DBD has been acting. Looking at the stock’s movement on the chart, Diebold Nixdorf, Incorporated recorded a 52-week high of $31.85. It is now trading 17.3% off that level. The stock is trading $17.59 its 50-day moving average by 3.04%. The stock carved out a 52-week low down at $14.30.

In recent action, Diebold Nixdorf, Incorporated (DBD) has made a move of -20.71% over the past month, which has come on Strong relative transaction volume. Over the trailing year, the stock is underperforming the S&P 500 by 12.51, and it’s gotten there by action that has been more volatile on a day-to-day basis than most other stocks on the exchange. In terms of the mechanics underlying that movement, traders will want to note that the stock is trading on a float of 19.94% with $74.47 Million sitting short, betting on future declines. That suggests something of the likelihood of a short squeeze in shares of DBD.

Previous articleHow Does American International Group, Inc. (AIG) Stack Up Right Now?
Next articlePhysicians Realty Trust (DOC): From Top to Bottom